$CDZI
CADIZ INC Stock $cdzi

$cdzi Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924016678 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$513.0K	$1.121M	$130.0K
YoY Change	-36.59%	762.31%	-8.45%
Cost Of Revenue	$852.0K	$1.004M	$22.00K
YoY Change	10.94%	4463.64%
Gross Profit	-$339.0K	$117.0K	$108.0K
YoY Change	-926.83%	8.33%
Gross Profit Margin	-66.08%	10.44%	83.08%
Selling, General & Admin	$6.305M	$4.730M	$3.953M
YoY Change	18.52%	19.66%	3.86%
% of Gross Profit		4042.74%	3660.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$305.0K	$295.0K	$329.0K
YoY Change	0.0%	-10.33%	171.9%
% of Gross Profit		252.14%	304.63%
Operating Expenses	$6.610M	$5.025M	$4.282M
YoY Change	17.51%	17.35%	9.04%
Operating Profit	-$6.949M	-$4.908M	-$4.152M
YoY Change	24.44%	18.21%	9.7%
Interest Expense	$1.921M	$1.939M	$1.504M
YoY Change	43.57%	28.92%	-24.46%
% of Operating Profit
Other Income/Expense, Net	$20.00K	-$294.0K
YoY Change
Pretax Income	-$8.870M	-$6.847M	-$10.69M
YoY Change	25.6%	-35.94%	85.06%
Income Tax	$2.000K	$3.000K	$2.000K
% Of Pretax Income
Net Earnings	-$8.872M	-$6.900M	-$10.70M
YoY Change	25.59%	-35.51%	80.99%
Net Earnings / Revenue	-1729.43%	-615.52%	-8230.77%
Basic Earnings Per Share	-$0.15	-$0.12	-$0.19
Diluted Earnings Per Share	-$0.15	-$0.12	-$0.19
COMMON SHARES
Basic Shares Outstanding	67.79M	67.06M	66.54M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.10M	$19.21M	$26.28M
YoY Change	-47.49%	-26.89%	39.63%
Cash & Equivalents	$10.10M	$19.21M	$26.28M
Short-Term Investments
Other Short-Term Assets	$1.006M	$993.0K	$2.955M
YoY Change	-47.08%	-66.4%	43.59%
Inventory	$4.497M	$2.756M
Prepaid Expenses
Receivables	$1.619M	$1.581M	$225.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$17.22M	$24.54M	$29.46M
YoY Change	-25.7%	-16.69%	40.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$87.03M	$87.05M	$85.20M
YoY Change	1.87%	2.17%	7.33%
Goodwill	$5.714M	$5.714M	$5.714M
YoY Change	0.0%	0.0%	49.86%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.365M	$5.398M	$5.001M
YoY Change	-1.97%	7.94%	9.5%
Total Long-Term Assets	$100.9M	$101.0M	$98.09M
YoY Change	3.29%	2.93%	-0.65%
TOTAL ASSETS
Total Short-Term Assets	$17.22M	$24.54M	$29.46M
Total Long-Term Assets	$100.9M	$101.0M	$98.09M
Total Assets	$118.1M	$125.5M	$127.5M
YoY Change	-2.27%	-1.6%	6.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.901M	$2.700M	$1.404M
YoY Change	63.46%	92.31%	28.22%
Accrued Expenses	$2.309M	$2.108M	$1.070M
YoY Change	42.27%	97.01%	-30.47%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$155.0K	$171.0K	$131.0K
YoY Change	21.09%	30.53%	59.76%
Total Short-Term Liabilities	$9.117M	$8.574M	$5.429M
YoY Change	58.06%	57.93%	35.52%
LONG-TERM LIABILITIES
Long-Term Debt	$54.72M	$54.23M	$36.62M
YoY Change	48.21%	48.09%	-22.13%
Other Long-Term Liabilities	$43.00K	$42.00K	$37.00K
YoY Change	13.16%	13.51%	12.12%
Total Long-Term Liabilities	$54.77M	$54.27M	$36.66M
YoY Change	48.17%	48.05%	-22.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.117M	$8.574M	$5.429M
Total Long-Term Liabilities	$54.77M	$54.27M	$36.66M
Total Liabilities	$90.54M	$88.90M	$66.73M
YoY Change	32.71%	33.23%	-9.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$658.1M	-$648.0M	-$615.3M
YoY Change	5.54%	5.32%	5.97%
Common Stock	$676.0K	$671.0K	$663.0K
YoY Change	1.81%	1.21%	31.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$27.57M	$36.61M	$60.82M
YoY Change
Total Liabilities & Shareholders Equity	$118.1M	$125.5M	$127.5M
YoY Change	-2.27%	-1.6%	6.52%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$8.872M	-$6.900M	-$10.70M
YoY Change	25.59%	-35.51%	80.99%
Depreciation, Depletion And Amortization	$305.0K	$295.0K	$329.0K
YoY Change	0.0%	-10.33%	171.9%
Cash From Operating Activities	-$7.063M	-$2.900M	-$4.100M
YoY Change	21.73%	-29.27%	28.13%
INVESTING ACTIVITIES
Capital Expenditures	$281.0K	$186.0K	$2.206M
YoY Change	-72.1%	-91.57%	316.23%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$281.0K	-$186.0K	-$2.206M
YoY Change	-72.1%	-91.57%	250.16%
FINANCING ACTIVITIES
Cash Dividend Paid		$1.288M	$1.288M
YoY Change		0.0%	0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$52.00K	$15.00M
YoY Change		-99.65%	42757.14%
Cash From Financing Activities	-1.766M	$17.77M	$21.27M
YoY Change	35.22%	-16.45%	104.14%
NET CHANGE
Cash From Operating Activities	-7.063M	-$2.900M	-$4.100M
Cash From Investing Activities	-281.0K	-$186.0K	-$2.206M
Cash From Financing Activities	-1.766M	$17.77M	$21.27M
Net Change In Cash	-9.110M	$14.71M	$14.99M
YoY Change	12.26%	-1.88%	128.33%
FREE CASH FLOW
Cash From Operating Activities	-$7.063M	-$2.900M	-$4.100M
Capital Expenditures	$281.0K	$186.0K	$2.206M
Free Cash Flow	-$7.344M	-$3.086M	-$6.306M
YoY Change	7.86%	-51.06%	69.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4152000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1336000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10689000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10691000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1265000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11956000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	329
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	329
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	329
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	329
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	85000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	85000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67283574
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67283574
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66710795
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	66710795
CY2024Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.08875	pure
CY2024Q1	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	550
CY2023Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.08875	pure
CY2023Q1	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	550
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67283574
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	0-12114
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0313235
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	550 South Hope Street, Suite 2850
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90071
CY2024Q1	dei	City Area Code CityAreaCode	213
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	271-1600
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	67793609
CY2024Q1	us-gaap	Revenues Revenues	1121000	usd
CY2023Q1	us-gaap	Revenues Revenues	130000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1004000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4730000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3931000	usd
CY2024Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	295000	usd
CY2023Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	329000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	6029000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	4282000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4908000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1939000	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	130000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5331000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6847000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6850000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1265000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8115000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2024Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	66997000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	62638000
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19212000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4502000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1581000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	904000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2756000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2106000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	993000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	508000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	24542000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	8020000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	87045000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	87217000	usd
CY2024Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	420000	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	420000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	5714000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	5714000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2254000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	431000	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	134000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	134000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5398000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5438000	usd
CY2024Q1	us-gaap	Assets Assets	125507000	usd
CY2023Q4	us-gaap	Assets Assets	107374000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2700000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1245000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2108000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1170000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	171000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	182000	usd
CY2024Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	1265000	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1288000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1450000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1450000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	723000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	373000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	157000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	127000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8574000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5835000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	54229000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	37711000	usd
CY2024Q1	cdzi	Lessor Operating Lease Deposit Liabilities LessorOperatingLeaseDepositLiabilities	23452000	usd
CY2023Q4	cdzi	Lessor Operating Lease Deposit Liabilities LessorOperatingLeaseDepositLiabilities	22877000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1974000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	318000	usd
CY2024Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	625000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	625000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	42000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	41000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	88896000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	67407000	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	671000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	665000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	683903000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	679150000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-647965000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-639850000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	36611000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	39967000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	125507000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	107374000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6850000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10691000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	295000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	329000	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	269000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	194000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	33000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	29000	usd
CY2024Q1	cdzi	Paid In Kind Interest Added To Loan Principal PaidInKindInterestAddedToLoanPrincipal	380000	usd
CY2023Q1	cdzi	Paid In Kind Interest Added To Loan Principal PaidInKindInterestAddedToLoanPrincipal	166000	usd
CY2024Q1	cdzi	Paid In Kind Interest Added To Lease Liability PaidInKindInterestAddedToLeaseLiability	569000	usd
CY2023Q1	cdzi	Paid In Kind Interest Added To Lease Liability PaidInKindInterestAddedToLeaseLiability	500000	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	307000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-0	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	130000	usd
CY2024Q1	cdzi	Gains Losses On Debt Conversion And Extinguishment Of Debt GainsLossesOnDebtConversionAndExtinguishmentOfDebt	-0	usd
CY2023Q1	cdzi	Gains Losses On Debt Conversion And Extinguishment Of Debt GainsLossesOnDebtConversionAndExtinguishmentOfDebt	-5331000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1259000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	326000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	677000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-229000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	650000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	582000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	485000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	412000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-40000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-29000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1485000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	523000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-170000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-26000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	350000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	972000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	116000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2873000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4069000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	186000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2206000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-186000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2206000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	38490000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	1288000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	1288000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	20000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	52000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	15047000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	839000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	27000	usd
CY2024Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	-0	usd
CY2023Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	600000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	52000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	261000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17769000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21267000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14710000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14992000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4636000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13782000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19346000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28774000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	39967000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1207000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	887000	usd
CY2024Q1	cdzi	Stock Issued During Period Value Issued To Lenders StockIssuedDuringPeriodValueIssuedToLenders	480000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	257000	usd
CY2024Q1	cdzi	Adjustment To Additional Paidin Capital Extinguishment Of Debt AdjustmentToAdditionalPaidinCapitalExtinguishmentOfDebt	1928000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1265000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6850000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	36611000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34223000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	65000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	38490000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1265000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10691000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	60822000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6900000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10700000	usd
CY2024Q1	cdzi	Working Capital WorkingCapital	16000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2900000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5300000	usd
CY2024Q1	us-gaap	Interest Paid InterestPaid	362000	usd
CY2024Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	380000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19212000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4502000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26277000	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1265000	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	134000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	134000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1232000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19346000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4636000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28774000	usd
CY2024Q1	us-gaap	Revenues Revenues	1121000	usd
CY2024Q1	us-gaap	Revenues Revenues	1121000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1004000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4730000	usd
CY2024Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	295000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	6029000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4908000	usd
CY2023Q1	us-gaap	Revenues Revenues	130000	usd
CY2023Q1	us-gaap	Revenues Revenues	130000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3931000	usd
CY2023Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	329000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	4282000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4152000	usd
CY2024Q1	us-gaap	Assets Assets	125507000	usd
CY2023Q4	us-gaap	Assets Assets	107374000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	5714000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	5714000	usd
CY2024Q1	cdzi	Adjustment To Additional Paidin Capital Extinguishment Of Debt AdjustmentToAdditionalPaidinCapitalExtinguishmentOfDebt	1900000	usd
CY2021Q2	cdzi	Water Supply Agreement Number Of Acrefeet Of Water Per Annum To Customer WaterSupplyAgreementNumberOfAcrefeetOfWaterPerAnnumToCustomer	9500	pure
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1259000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	326000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9456000
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1819000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1450000	usd
CY2024Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1450000	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	85000000
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67283574
	us-gaap	Payments Of Dividends PaymentsOfDividends	12949000	usd

Files In Submission

Name	View Source	Status
0001437749-24-016678-index-headers.html	Edgar Link	pending
0001437749-24-016678-index.html	Edgar Link	pending
0001437749-24-016678.txt	Edgar Link	pending
0001437749-24-016678-xbrl.zip	Edgar Link	pending
cdzi-20240331.xsd	Edgar Link	pending
cdzi20240331_10q.htm	Edgar Link	pending
ex_672239.htm	Edgar Link	pending
ex_672240.htm	Edgar Link	pending
ex_672241.htm	Edgar Link	pending
ex_672242.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
cdzi-20240331_def.xml	Edgar Link	unprocessable
cdzi-20240331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cdzi20240331_10q_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cdzi-20240331_pre.xml	Edgar Link	unprocessable
cdzi-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDZI
CADIZ INC Stock $cdzi

2024 Q2 Form 10-Q Financial Statement

#000143774924016678 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDZI CADIZ INC Stock $cdzi

2024 Q2 Form 10-Q Financial Statement

#000143774924016678 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDZI
CADIZ INC Stock $cdzi